Latest news for health care topics. Include medical news , health insurance , therapy and vaccine news

Monday, August 7, 2017

Fresenius Medical Care to Acquire NxStage Medical, Inc. to Strengthen its Vertically Integrated Dialysis Business quoting : Markets Insider

Media Contact:Fresenius Medical Care GroupJoachim WeithT: +49-6172-609-2101rel="nofollow">joachim.weith@fresenius.comFresenius Medical Care North AmericaKatherine DobbsT: +1-781-699-9039rel="nofollow">Katherine.dobbs@fmc-na.comContact for analysts and investors:Dr. Dominik HegerT: +49-6172-609-2601rel="nofollow">dominik.heger@fmc-ag.comNxStage Contact:Kristen K. Sheppard, Esq. Through its network of 3,690 dialysis clinics, Fresenius Medical Care provides dialysis treatments for 315,305 patients around the globe. Fresenius Medical Care expects the acquisition to be accretive to net income and EPS within three years from closing. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and on the New York Stock Exchange (FMS).



Fresenius Medical Care to Acquire NxStage Medical, Inc. to Strengthen its Vertically Integrated Dialysis Business
Market Data provided by Interactive Data (Terms & Conditions). Real-time quotes provided by BATS BZX Real-Time Price. Economic data provided by Econoday. Mutual fund and ETF data provided by Lipper. Company fundamental data provided by Morningstar.

Fresenius Medical Care to buy NxStage for $2 bln

Fresenius Medical Care is part of German healthcare company Fresenius SE & Co. KGaA (FRE.XE). The deal has been approved by NxStage's board, but still requires approval by NxStage stockholders and regulators, Fresenius Medical Care said in a statement. FRANKFURT--Fresenius Medical Care AG & Co. KGaA said on Monday it would acquire NxStage Medical Inc. for around $2 billion to boost its kidney dialysis business. Fresenius Medical Care said the deal would be cash and debt financed, with before-tax cost synergies of around $80-$100 million expected over three to five years. The acquisition will likely involve intergration costs of around $150 million, the German company said.


collected by :Lucy William

To follow all the new news about Health care

No comments:

Post a Comment